Filamin 1 Activators
Common Filamin 1 Activators include, but are not limited to Resveratrol CAS 501-36-0, Curcumin CAS 458-37-7, PGE2 CAS 363-24-6, Retinoic Acid, all trans CAS 302-79-4 and Suberoylanilide Hydroxamic Acid CAS 149647-78-9.
Filamin 1 Activators represent a distinctive chemical class endowed with the capability to intricately modulate the activity of Filamin 1 (FLNA), a cytoskeletal protein recognized for its pivotal role in governing fundamental cellular processes. FLNA, also denoted as Filamin 1, assumes a multifaceted role in cellular architecture, migration, adhesion, and signal transduction. Operating as an actin-crosslinking protein, FLNA contributes significantly to the maintenance of cell shape and the orchestration of the cytoskeletal framework, thus intricately influencing cellular structure. At the crux of its functional intricacies, Filamin 1 engages in actin-crosslinking, effectively crafting a scaffold that not only maintains cellular morphology but also intricately organizes the cytoskeleton-a fundamental underpinning of cellular architecture. Beyond this foundational role, Filamin 1 establishes an extensive network of interactions with diverse cellular components, including transmembrane receptors, signaling molecules, and other cytoskeletal elements. This expansive interactome underscores Filamin 1 as a keystone regulator, orchestrating a myriad of cellular processes that collectively shape cellular behavior.
Filamin 1 Activators, within this scientific context, emerge as compounds capable of exerting influence on Filamin 1 function. Their impact may manifest through intricate mechanisms, such as influencing the binding interactions of Filamin 1 with other cellular components or inducing alterations in its conformation. The consequential modulation of Filamin 1 activity by these activators holds the promise of influencing critical cellular processes, particularly in the domains of adhesion, migration, and signaling. Exploring the potential ramifications of Filamin 1 Activators necessitates a nuanced examination of their impact on Filamin 1 within the cellular milieu. The intricate dance of cellular adhesion, migration, and signaling may be subject to modulation, as these compounds delicately influence the interactions and dynamics of Filamin 1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol might influence FLNA expression through interactions with cellular stress response pathways. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin's impact on FLNA might involve modulation of cellular signaling pathways and gene expression related to FLNA. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 activates G protein-coupled receptors, leading to downstream transcriptional activation of FLNA. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid interacts with RARs and RAREs in the FLNA gene promoter, leading to increased FLNA expression. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
PD 0332991 is a CDK4/6 inhibitor that affects the cell cycle by inhibiting cyclin-dependent kinases (CDKs), including CDK4 and CDK6. By inhibiting CDK4/6, PD 0332991 can reduce phosphorylation of the retinoblastoma protein (Rb), leading to the activation of E2F transcription factors. E2F factors can then induce the expression of genes, including FLNA, involved in cell cycle progression and other cellular processes. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA is an HDAC inhibitor that affects gene expression by inhibiting histone deacetylases (HDACs). Inhibition of HDACs leads to increased histone acetylation, resulting in a more open chromatin structure. This can enhance the accessibility of transcription factors, including those that regulate FLNA expression, to the FLNA gene promoter, promoting gene transcription and expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
Estradiol, a form of estrogen, can potentially influence FLNA expression through receptor-mediated signaling and gene regulation. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone, a glucocorticoid, might modulate FLNA expression as part of its broader effects on gene expression and cellular processes. | ||||||